Bank your future: Insemination and semen cryopreservation. Disclosure. Lecture objectives

Similar documents
The new 5 th WHO manual semen parameter reference values do they help or hinder?

Male Fertility: Your Questions Answered

Testosterone Therapy-Male Infertility

Use of donor semen in the treatment of

Novel Technologies for Selecting the Best Sperm for IVF and ICSI

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates

Outline. History of sperm freezing. Testicular tissue: When and how should it be cryopreserved?

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

FACT SHEET. Failure of Ovulation Blocked or Damaged Fallopian TubesHostile Cervical Mucus Endometriosis Fibroids

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Optimize your success

OVERVIEW AND FACTS: CRYOPRESERVATION

Fertility care for women diagnosed with cancer

Number of oocytes and live births in IVF

Clinical Policy Committee

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception

Introduction. Introduction. Assisted reproduction using donor sperm bank IUI IVF ICSI. Andrology Laboratory IVI Madrid. Dr.

Adoption and Foster Care

Reproductive Technology, Genetic Testing, and Gene Therapy

Male fertility and infertility

Sperm Function Tests Beyond the Semen Analysis

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Therapeutic Sperm Banking

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

ESHRE Andrology Campus Course Reproductive Andrology Brussels 8-10 November 2007

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Fertility Services Commissioning Policy

Clinical Policy Committee

Reversible Conditions Organising More Information semen analysis Male Infertility at Melbourne IVF Fertility Preservation

Fertility treatment and referral criteria for tertiary level assisted conception

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Fertility Services Commissioning Policy

Oncofertility: The Story of the Spermatogonial Stem Cell

OUTCOME OF TREATMENT FOR OAT SYNDROME BY INTRACYTOPLASMIC SPERM INJECTION AT THE ART CENTER

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Fertility Services Commissioning Policy

Evaluation of Serial Thawing-Refreezing on Human Spermatozoa Resistance Using Cryovials and Straws

Policy statement. Commissioning of Fertility treatments

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

Fertility assessment and assisted conception

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

Fertility Assisted Conception Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Patient Price List. t: e: w:

When should I ask my doctor about my fertility?

Selection of sperm for ICSI: hyaluronan binding

National Fertility Preservation Register: datatabase to help cancer patients with fertility issues

Wiltshire CCG Fertility Policy

The effects of cancer treatment on male infertility

Biology of fertility control. Higher Human Biology

LCCG Fertility Services Commissioning Policy

IVF: PAST, PRESENT AND FUTURE

Semen analysis report. 2nd symposium of Croatian Society of Clinical Embryologist and Andrology Workshop, Opatija, November, 2014

Male infertility too often ignored & forgotten

Can I still have children? Information for men having chemotherapy and radiotherapy

Name of Policy: Laboratory Tests of Sperm Maturity, Function and DNA Integrity

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

POST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE. Anatomy : Male and Female genital tract

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

IN VITRO FERTILISATION (IVF)

Leicester City, East Leicestershire and Rutland & West Leicestershire Collaborative Commissioning Policy Gamete/Embryo cryopreservation

SpermComet DNA Test your results and what they mean

Brighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director

Storage of sperm prior to treatment for cancer

Policy statement. Fertility treatments. This policy is unchanged from the version approved by the CCG in July 2014.

Cycle Plan Page1 CYCLE PLAN TYPE CYCLE TYPE: Initial Plan Updated Plan Management Team Review Monitoring Review

Information for men wishing to freeze sperm for fertility preservation Nov

Planning for Parenthood After a Cancer Diagnosis

THE INFLUENCE OF EJACULATORY ABSTINENCE INTERVALS ON SEMEN QUALITY - OLD CONCEPT, NEW EVIDENCES

Bumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.

The evidence for insemination versus intercourse or IVF

Fertility What do GP s need to know? Richard Fisher Fertility Associates

Possibilities Plan. Access to the care you need.

The sperm HBA that has been developed as a commercial diagnostic kit for assessing sperm. Proceedings of Singapore Healthcare Volume 22 Number

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.

Recommended Interim Policy Statement 150: Assisted Conception Services

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Role of pre and postsurgical. cryopreservation. Centre for Public Health Queen s University Belfast

We can give you the very best chance of having a baby.

Infertility treatment

DIABLO VALLEY ESTATE PLANNING COUNCIL THE NEW BIOLOGY: WHAT DO ESTATE PLANNERS NEED TO KNOW ABOUT ASSISTED REPRODUCTION OCTOBER 15, 2014

Understanding IVF Processes in Surrogacy

PROCEDURES LAPAROSCOPY

Tammie Roy Genea Biomedx Sydney, Australia. Declared to be stakeholder in Genea Biomedx

INTRODUCTION TABLE OF CONTENTS. If you want to become a parent after cancer, we would like to give you the information you need to make that happen.

Effect of chemo- or radiotherapeutic agents on human sperm: the reproductive needs of young male cancer survivors. Ghamartaj-Hosseini

Fertility Policy. December Introduction

Your baby, a unique conception

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE

Over. years. dedicated to women s health

IVF. NHS North West London CCGs

Information about The Storage of Sperm, Eggs and Embryos before starting Chemo or Radiotherapy Treatment

Always placing innovation and excellence at the heart of our strategy, clinique ovo aims to meet your expectations and support your family project.

1 - Advanced clinical course for ART with Hands on

Director of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017

Transcription:

Bank your future: Insemination and semen cryopreservation Roelof Menkveld, PhD Andrology Laboratory, Department of Obstetrics and Gynaecology, Tygerberg Academic Hospital and University of Stellenbosch. ESHRE Task Force for Developing Countries and Infertility and ESHRE SIG-Andrology Campus Meeting on Artificial insemination: an update Genk, Belgium 13 15 December 2009 Disclosure I have no commercial or other activities that may reflect on the contents of this lecture Lecture objectives Give an short overview of reasons for cryopreservation of semen Discuss the possible effects of cryopreservation on semen parameters and sperm function Discuss the use(fulness) of cryopreserved semen in practice

Reasons for cryopreservation of semen Fertility preservation in male cancer patients Donor inseminations Treatment of male and female subfertility Back up for assisted reproductive procedures Fertility preservation before vasectomy Separation of X and Y bearing spermatozoa Fertility preservation in male cancer patients Effect of Chemotherapy (1) Interrupt cellular proliferation Germinal epithelium cells more susceptible than Leydig cells May cause mutagenic changes in spermatozoa Non permanent increase in aneuploidy Schmidt et al., Int J Androl, 2007

Effect of Chemotherapy (2) May negatively effect semen parameters May negatively effect sperm functions and DNA status Increased risk of azoospermia Negative effect on semen parameters Parameter Patients Controls Adolescent cancer patients (n=205) Volume (ml) 1.6 3.0 Count (10 6 /ml) 50.6 84.5 Motility (%) 45.1 68.5 Testicular cancer (n=83) Count (10 6 /ml) 15.0 48.0 Leukemia Count (10 6 /ml) 19.5 106.0 Motility (%) 45.0 64.0 Agarwal and Allamaneni, J Natl Cancer Inst Monogr, 2005 Negative effects on sperm function Most important negative effect is influence on sperm DNA integrity Poorsperm DNA integrity leads to Lower fertilisation rates Poorer embryo quality Lower pregnancy rates

Negative effect of cancer on sperm DNA Test Patients Controls Halosperm (1) 34.3% 10.8% TUNEL (2) 50±3.4% 40±3.1% CMA3 (3) 63.0 30.2 TUNEL (3) 21.0 9.7 Comet assay (4) 50.1 13.9 (Abnormal values) 1= Meseguer et al., Fertil Steril, 2007; 2 = Edelstein et al., Fertil Steril, 2007; 3 = Spermon et al., Hum Rerprod, 2006; 4 = O Donovan, Andrologia, 2005 Fertility after cancer treatment General Before treatment 91.2% of patients fathered a child After treatment 67.1% of patients fathered a child Five year cumulative pregnancy index (CPI) = 85% Schmidt et al., Int J Androl, 2007 Effect of cancer treatment on semen parameters With radiotherapy 1 year post treatment (normozoospermic men) 16% were oligozoospermia 20% were still azoospermia Spermatogenesis continues to improve over next 5 years Simons et al., CA Cancer J Clin, 2005

Conservation of fertility by cryopreservation in cancer patients Is a very important option for cancer patients Other preservation options available for cancer patients especially young boys Testicular tissue banking Spermatogonial stem cell banking and in vitro maturation Effect of semen cryopreservation onsemen parameters and sperm functions Effect of cryopreservation on semen parameters in cancer patients (n = 64) Before freezing After freezing Mean (SD) Range Mean (SD) Range Volume (ml) 28 2.8 ± 15 1.5 05 0.5 70 7.0 Count (10 6 /ml) 39.4 ± 28.7 0.1 100.0 18.4 ± 13.5 4.5 40.0 Motility (% a+b) 45.3 ± 11.3 0.0 60.0 23.3 ± 12.1 0.0 40.0 Morphology (% normal) 5.8 ±5.2 1.0 16.0 Menkveld Unpublished data

Effect of cryopreservation on spermatozoa and sperm structure and function Semen parameters Reduced motility Reduced vitality Structural and functional damage Reduction of intact acrosomes Reduction of acrosin activity Alternations in acrosome structure Shrinkage of nuclei and cytoplasmic membranes Loss of plasma membrane integrity Thus reduction in fertilisation potential Nijs et al, RMB Online, 2009 Effect of long term semen cryopreservation on sperm DNA Short term storage for 1 5 years (n= 14) Long term storage for 9 13 years (n = 16) DNA integrity (TUNEL assay) Short term storage = 31% fragmentation Long term storage = 37% fragmentation Original DNA fragmentation = not known Edelstein et al., Fertil Steril., 2009; 90(4):1327-1330 Effect of cryopreservation on sperm binding function Sperm Hyaluronan Binding assay HA binding before freezing= 68.5% HA binding after freezing= 71.3% = No effect Nijs et al., RMB Online 19(2):202-206,2009

Use(fulness) of cryopreserved semen in practice Survey of use of semen cryopreservation in cancer patients Australia and New Zealand (1) Paediatric Oncology Centres 12/13 responded 12 offered semen cryopreservation (SCP) Only 9/12 (75%) offered counselling USA (2) Oncologists 91% agree that SCP should be offered 10% offers always 27% offers sometimes (1) Heath and Stern, 2006; (2) Rofeim and Gilbert, 2004 Use of cryopreserved semen samples in cancer patients Magelssen et al., 2005 7% (29/393) of men used their samples 1 time 55.1% (16/29) achieved pregnancy 17% (67/393) achieved pregnancy without use of their CPS 21% (205/966) patients without CPS achieved pregnancies Simons et al., 2005 Up to 30% but often <10% use their CPS

Use of cryopreserved semen samples in cancer patients Chung et al., 2004 Less then 5% Ragni et al., 2003 (15 year period) 5.2% (36/686) used CPS for ART Cumulative rates 4, 8 and 12 years = 4.5%, 8.7% and 11.8% Use of cryopreserved semen in cancer patients Own experience Background data Number of patients = 64 Age (years) = 25.3 ± 5.4 (15.7 40.1) Samples/ patient = 2.4 ± 0.9 (1.0 5.0) Number of straws = 18.1 ± 10.0 (2.0 39.0) Number of patients who used frozen semen samples 3/64 = 4.7% Used for ICSI = 2 IUI = 3 GIFT = 1 Menkveld unpublished data Long term use of cryopreserved semen Successful sperm storage for 28 years Cryopreservation before cancer treatment IUI with cryopreserved semen resulted in a live birth after 21 years Second successful IUI with same stored sample resulted in a second live birth after 28 years Feldschuh et al., Fertil Steril., 2005; 84(4):1017

Use of cryopreservation of semen for treatment of male subfertility Study design Males frequently provided semen samples Samples were cryopreserved Best samples of each male was used for IUI + fresh sample Cumulative and average pregnancy rates per cycle Control group Fresh semen samples only = 9/77(13%) and 4.1% Test group Frozen + fresh sample = 19/73 (27.1%) and 9.1% Aboulghar et al., Fertil Steril 56(6):1151-5,1991 Use of semen cryopreservation for sex selection Separation of X and Y bearing spermatozoa Flow cytometry 5871 sorts 74.9% X and 25.1 Y Post sort purity X sort = 87.9% Y sort = 73.4% IUI cycles = 3629 Pregnancy rate = 15.6% Miscarriage rate =15.7% Babies X sort = 92.0% Y sort = 81.5% Karabinus, 2009

Conclusions Semen cryopreservation is an essential tool in assisted reproductive procedures IUI with cryopreserved (non donor) semen is mainly used for cancer patients In subfertile patients mainly used for IVF ICSI due to mostly poor semen quality in infertile males Tygerberg Academic Hospital and University of Stellenbosch Medical School, Tygerberg (Cape Town), South Africa Thank you for your attention